|
|
|
08 Feb 2007 |
FDA Approves Orlistat for Over-the-Counter Use
|
|
06 Feb 2007 |
Arena Pharmaceuticals Completes Enrollment with 3,182 Patients in Lorcaserin Phase 3 BLOOM Trial for Obesity
|
|
05 Feb 2007 |
Dosing convenience is mandatory to keep pace in the pipeline race of GLP-1 analogs for type 2 diabetes
|
|
02 Feb 2007 |
Metabasis Announces Completion of Enrollment in the Phase 2b Clinical Trial for CS-917 in Patients With Type 2 Diabetes
|
|
02 Feb 2007 |
Alnylam Presents Pre-clinical Results from Hypercholesterolemia, Huntington's Disease and Neuropathic Pain Programs at Keystone Symposium on RNAi
|
|
02 Feb 2007 |
Successful Oral Insulin Toxicity Result - Oradel(TM), Loaded With Generic Insulin
|
|
01 Feb 2007 |
AstraZeneca and Palatin Technologies Announce Worldwide Collaboration to Discover, Develop and Commercialise Obesity Compounds
|
|
01 Feb 2007 |
Theratechnologies launches confirmatory Phase 3 trial testing TH9507
|
|
30 Jan 2007 |
LCT to start clinical trial of type 1 diabetes treatment
|
|
26 Jan 2007 |
JANUVIA(TM), First in New Class of Oral Treatments Known as DPP-4 Inhibitors, Recommended for Approval for the Treatment of Type 2 Diabetes in the European Union
|
|
26 Jan 2007 |
Altea Therapeutics Announces Positive Clinical Results for its Basal Insulin Transdermal Patch
|
|
25 Jan 2007 |
Obecure Recruits First Patient in Phase II Obesity Study
|
|
18 Jan 2007 |
Genaera Corporation Announces Presentation Of Data On Trodusquemine Mechanism Of Action In Obesity
|
|
18 Jan 2007 |
Marketing Authorisation Granted for Tandemact (TM) (pioglitazone/glimepiride) for Type 2 Diabetes in Europe
|
|
18 Jan 2007 |
Metabolex Shows MBX-102/JNJ-39659100 Reduces Inflammation in Preclinical Models of Diabetes
|
|
18 Jan 2007 |
Elixir Pharmaceuticals Presents Ghrelin Antagonist Program at European Conference on Aging
|
|
17 Jan 2007 |
Merck Serono Announces Positive Results From Phase III Diet Study Of Phenoptin For Phenylketonuria
|
|
17 Jan 2007 |
Largest-ever Fabry study shows earlier treatment with (Pr)Fabrazyme(R) 1 mg/kg means less damage from rare Fabry disease
|
|
17 Jan 2007 |
Merrion Announces Positive Clinical Results for Osteoporosis Drug MER 103
|
|
16 Jan 2007 |
Genzyme Announces Publication of Study Showing Impact of Cerezyme on Bone Health for Patients with Type 1 Gaucher Disease
|
|
16 Jan 2007 |
FDA accepts for filing a New Drug Application (NDA) for Somatuline(R) Autogel(R)
|
|
12 Jan 2007 |
ELAPRASE for the treatment of Hunter syndrome approved by the European Commission
|
|
12 Jan 2007 |
Bristol-Myers Squibb and AstraZeneca Announce Worldwide Collaboration to Develop and Commercialize Diabetes Compounds
|
|
11 Jan 2007 |
The right balance drives the field of PPAR agonist R&D
|
|
11 Jan 2007 |
InteKrin Therapeutics Licenses Diabetes Product
|
|
11 Jan 2007 |
New England Journal of Medicine Reports Aegerion's Lead Compound Reduces LDL By 51% in Patients With a Severe Form of Hypercholesterolemia
|
|
11 Jan 2007 |
Sembiosys’ Plant-Produced Insulin Chemically And Physiologically Equivalent To Commericial Insulin In Animal Studies
|
|
09 Jan 2007 |
Incyte to Report Positive Preliminary Clinical Results from HIV and Diabetes Programs and Highlight Progress in Several Drug Development Programs at the 25th JPMorgan Healthcare Conference
|
|
09 Jan 2007 |
Alkermes and Lilly Expand AIR(R) Inhaled Insulin Collaboration
|
|
09 Jan 2007 |
Quatrx Pharmaceuticals Reports Positive Results From A Phase 2 Trial Of Fispemifene
|
|
08 Jan 2007 |
Catalyst Biosciences And Wyeth Pharmaceuticals Sign Two Agreements For Novel Biotherapeutic Platform Of Engineered Proteases
|
|
06 Jan 2007 |
OSI Pharmaceuticals Licenses Its Glucokinase Activator Program for the Treatment of Type 2 Diabetes to Eli Lilly and Company
|
|
04 Jan 2007 |
FDA Approves BYETTA(R) (exenatide) Injection for Expanded Combination Use
|
|
04 Jan 2007 |
MacroGenics and JDRF Form Partnership to Support Pivotal Phase II/III Clinical Trial of Anti-CD3 Monoclonal Antibody for Children and Adults With Recent-Onset Type 1 Diabetes
|
|
03 Jan 2007 |
Daiichi Sankyo, Inc. Announces Filing Of Supplemental New Drug Application For WelChol In The Treatment Of Type 2 Diabetes Mellitus
|
|
27 Dec 2006 |
Astellas Pharma US, Inc. Submits Supplemental New Drug Application For Antifungal Product Mycamine
|
|
23 Dec 2006 |
FDA Approves BYETTA(R) (exenatide) Injection for Expanded Combination Use
|
|
21 Dec 2006 |
FDA Accepts LifeCycle Pharma A/S’ New Drug Application for LCP-FenoChol for Review
|
|
21 Dec 2006 |
Nastech Reports Positive PYY Nasal Spray Clinical Trial Data and Will Advance Obesity Clinical Program in 2007
|
|
21 Dec 2006 |
Positive Opinion From European Regulatory Authorities for combination use of Actos® (Pioglitazone HCl) With Insulin for Type 2 Diabetes
|
|
21 Dec 2006 |
Repros’ Androxal Shows Noninferiority in Interim Phase 3 Analysis
|
|
21 Dec 2006 |
Metabolex Begins Phase 2A, Proof-of-Concept Study for MBX-2044 Diabetes Drug
|
|
20 Dec 2006 |
Theratechnologies Reports Positive Phase 3 Results for TH9507 in HIV associated Lipodystrophy
|
|
19 Dec 2006 |
BioMarin Announces Positive Results From Phase 3 Extension Study of Phenoptin for PKU
|
|
16 Dec 2006 |
Nippon Shinyaku Co., Ltd and Roche terminate NS-220 License Agreement
|
|
15 Dec 2006 |
Amicus Therapeutics Commences Phase 1 Clinical Trials For AT2220 For Pompe Disease
|
|
14 Dec 2006 |
GTx Announces That Ostarine Achieved Primary Endpoint of Lean Body Mass and a Secondary Endpoint of Improved Functional Performance in a Phase II Clinical Trial and Reacquisition of Full Rights to GTx SARM Program
|
|
14 Dec 2006 |
MicroIslet Holds Positive Pre-IND Meeting With FDA
|
|
13 Dec 2006 |
Apollo oral insulin update
|
|
12 Dec 2006 |
Vernalis Plc Initiates a Phase I Trial of a Promising New Approach to Treating Obesity and Related Disorders - Including Type II Diabetes
|
| |
|
Results 701 - 750 of 1094 |
